Are you impressed when NASA manages to calculate the time and speed of a rocket’s trajectory? A new study shows that your brain has a “nerd centre” capable of even more complex calculations.
Ieva Rauluševičiūtė is a Doctoral Research Fellow in the Mathelier group at NCMM. She recently spent one month with the groups of Dr Judith Zaugg and Dr Arnaud Krebs at the EMBL Headquarters in Heidelberg, Germany.
NCMM is delighted to announce that Dr Charlotte Boccara has been recruited as a new group leader under the Centre’s precision medicine umbrella. Dr Boccara will join us in April 2022 . She will establish and head the Systems Neuroscience & Sleep group at NCMM, aiming to decode sleep function in healthy development.
In this article, we meet NCMM Group Leader and Zebrafish Core Facility Leader, Camila Esguerra, and learn about the power of zebrafish as a model organism and the core facility she directs at the University of Oslo.
NCMM is delighted to announce that Dr Biswajyoti Sahu has been recruited as a new group leader for Precision Medicine. Dr Sahu will join us in September 2022 from the University of Helsinki, Finland.
NCMM Group Leader Sebastian Waszak and his team are advancing the understanding of childhood brain tumor evolution, exploring new approaches to molecular diagnostics, and utilizing knowledge gained from clinical cancer genomics.
Anne Martina Kraus and Sophie Mottl are combining their clinical training with computational methods to understand the genetics of childhood brain tumors
NCMM group leader Dr Emma Haapaniemi, Professor Eivind Valen and collaborators will advance gene therapy for primary immunodeficiencies
The Norwegian research environment stands to benefit from the launch of the new European Molecular Biology Laboratory programme ‘Molecules to Ecosystems’
Joint seed funding from NCMM and UiT has been awarded to four projects investigating lung cancer treatment, pathogenic bacterial cells, breast cancer metastasis and kidney inflammation progression.
Torfinn is starting on the 1st of February 2022 and will be joining NCMM’s IT team. He will be working with NCMM’s computer servers.
NCMM group leader, Dr. Irep Gözen, and collaborators have been awarded the large, interdisciplinary research project grant from the Research Council of Norway and the University of Oslo
The Mathelier group and collaborators recently published the 9th release of the JASPAR database, now expanded with more than 600 new transcription factor binding profiles. JASPAR continues to be an important open-access resource for the study of gene expression regulation.
A group of Nordic researchers has discovered a novel immune deficiency disease affecting the regulation of the immune system. A mutation in the IKZF2 gene was identified in a Finnish family with recurrent infections and signs of immune over activation.
Gözen group publishes paper entitled Mixed fatty acid-phospholipid protocell networks in the journal Physical Chemistry Chemical Physics.
Haapaniemi group sheds light on new mechanisms for improving the speed and accuracy of genome editing.
Nuru is starting on 2 December and will be working with NCMM communications. She will be responsible for profiling researchers, highlighting publications and achievements, covering events and creating content for the website.
Poul Nissen, Director of DANDRITE, NCMM's sister centre in Denmark, received the Anders Jahre Senior Medical Prize 2021 in Oslo in November.
The funding will enable ongoing collaboration between Daniel, the Kuijjer group and the Oslo University Hospital.
NCMM and IBV at the University of Oslo hosted the 7th NorMIC Imaging Workshop, focusing on methods in optical microscopy and 3D printing for microscopes.
During 8-19 November, NCMM hosted its annual PhD course in Molecular Medicine, strengthening scientific exchange and interactions in the Nordic countries.
After nearly two years of zoom-based seminars, NCMM was delighted to welcome international guest lectures from Professor Samuli Ripatti and Dr. Elisabeth Widén from FIMM, our sister Centre in Finland.
The Norwegian Cancer Society has granted the Haapaniemi group NOK 7 970 000 for developing CRISPR-Cas gene therapy for blood cancer predisposition syndromes 2022-2025.
The Biomechanics workshop organized by Irep Gözen from NCMM, and Andreas Carlson and Kent-Andre Mardal from the Department of Mathematics, brought together researchers from different fields and different corners of the world, all with an interest in mechanical processes of biology.
NCMM is pleased to announce allocating 6.7 million NOK in funding for 11 new collaborative projects between NCMM group leaders and the wider Associate Investigator network.